Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 11Unknown 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Carcinoma, Non-Small-Cell Lung 38Lung Neoplasms 9Adenocarcinoma of Lung 9NSCLC 5Brain Neoplasms 5Adenocarcinoma, Bronchiolo-Alveolar 3Neoplasms 2Adenocarcinoma 2Triple Negative Breast Neoplasms 1Skin Neoplasms 1Non-squamous Non-small Cell Lung Cancer 1Non-Small-Cell Lung 1Liver Neoplasms 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1Esophageal Neoplasms 1EGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors 1EGFR Mutation Positive Non-small Cell Lung Cancer 1Drug-Related Side Effects and Adverse Reactions 1Breast Neoplasms 1Advanced Stage Non Small Cell Lung Cancer 1Advanced Non-small Cell Lung Cancer 1Advanced NSCLC With EGFR Mutation 1

Interventions

Exercise 19Drug Therapy 18pembrolizumab 13Capecitabine 11Blood Specimen Collection 11Surveys and Questionnaires 10Radiotherapy 10Paclitaxel 9Dexamethasone 9Nivolumab 8Standard of Care 7Oxaliplatin 7Fluorouracil 7Erlotinib Hydrochloride 7apatinib 6Interviews as Topic 6Gemcitabine 6Control Groups 6Cisplatin 6Therapeutics 5Neoadjuvant Therapy 5Mindfulness-Based Cognitive Therapy 5Metformin 5Injections 5Everolimus 5Docetaxel 5Cyclophosphamide 5Bevacizumab 5sintilimab 4atezolizumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Neoplasms × Gefitinib × Clear all
NCT03239015 2022-03-04

Efficacy and Safety of Precision Therapy in Refractory Tumor

Shanghai Changzheng Hospital

Phase 2 Unknown
300 enrolled
Tumor-Agnostic

Neoplasms

NCT02929693 2019-04-11

Clinical Study of YYJD Decoction Combined With Gefitinib in Advanced Pulmonary Adenocarcinoma

Shanghai University of Traditional Chinese Medicine

Phase 3 Unknown
198 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡